Author:
Mallo M,Cervera J,Schanz J,Such E,García-Manero G,Luño E,Steidl C,Espinet B,Vallespí T,Germing U,Blum S,Ohyashiki K,Grau J,Pfeilstöcker M,Hernández J M,Noesslinger T,Giagounidis A,Aul C,Calasanz M J,Martín M L,Valent P,Collado R,Haferlach C,Fonatsch C,Lübbert M,Stauder R,Hildebrandt B,Krieger O,Pedro C,Arenillas L,Sanz M Á,Valencia A,Florensa L,Sanz G F,Haase D,Solé F
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference34 articles.
1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189–199.
2. Brunning RD, Bennett J, Flandrin G, Matutes E, Head D, Vardiman JW et al. Myelodysplastic Syndromes. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues. IARC: Lyon, 2001. pp. 61–73.
3. Brunning RD, Orazi A, Germing U, Le Beau MM, Porwit A, Baumann I et al. Myelodysplastic Syndromes. In: Swederlow SH, Campo E, Lee Harris N, Jaffe ES, Pileri SA, Stein H et al. (eds). WHO classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC: Lyon, 2008. pp. 87–107.
4. Bernasconi P, Klersy C, Boni M, Cavigliano PM, Calatroni S, Giardini I et al. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. Br J Haematol 2007; 137: 193–205.
5. Haase D, Germing U, Schanz J, Pfeilstocker M, Nosslinger T, Hildebrandt B et al. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 2007; 110: 4385–4395.
Cited by
104 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献